COVID-19 rebound after taking Paxlovid likely due to insufficient drug exposure

Paxlovid is the leading oral medication for preventing severe cases of COVID-19 in high-risk individuals. However, symptoms returned in some patients after treatment was completed, prompting the Centers for Disease Control and Prevention (CDC) to issue a health advisory on this so-called "COVID-19 rebound."

from Breaking World Pharma News https://ift.tt/XbVtaAC